| 99 | 3 | 74 |
| 下载次数 | 被引频次 | 阅读次数 |
子宫内膜增生是妇科常见病，被定义为子宫内膜增生程度超出正常增生范畴，分为子宫内膜增生不伴非典型性和子宫内膜非典型增生，多见于育龄期妇女，临床症状常表现为异常子宫出血，往往合并子宫内膜息肉、多囊卵巢综合征(PCOS)等疾病，同时也可能影响患者的生育功能。对于子宫内膜增生的治疗，宫腔镜手术、药物治疗及术后的长期管理等在其治疗过程中均非常重要，需要结合患者的症状、年龄、有无合并其他疾病、有无生育需要等因素进行个体化治疗。本文回顾性分析了1例子宫内膜增生合并PCOS且有生育需求的患者的诊疗过程，并对相关文献进行了复习。
Abstract：[1] 全国卫生产业企业管理协会妇幼健康产业分会生殖内分泌学组.中国子宫内膜增生诊疗共识[J].生殖医学杂志，2017,26:957-960.
[2] 李雷，陈晓军，崔满华，等.中国子宫内膜增生管理指南[J].中华妇产科杂志，2022,57:566-574.
[3] 中华医学会妇产科学分会妇科内分泌学组.异常子宫出血诊断与治疗指南(2022更新版)[J].中华妇产科杂志，2022,57:481-490.
[4] Sanderson PA,Critchley HO,Williams AR,et al.New concepts for an old problem:the diagnosis of endometrial hyperplasia[J].Hum Reprod Update,2017,23:232-254.
[5] WHO Classification of Tumours Editorial Board(ed).WHO classification of tumours:Female genital tumours[M].5th.Lyon:IARC Publications,2020:248-251.
[6] An H,Li T,Huang K,et al.Pregnancy outcomes in infertile patients with endometrial hyperplasia with or without atypia undergoing in vitro fertilization:the early-follicular long protocol is superior to midluteal long protocol[J].Front Endocrinol(Lausanne),2024,15,1314432.
[7] Chandra V,Kim JJ,Benbrook DM,et al.Therapeutic options for management of endometrial hyperplasia[J].J Gynecol Oncol,2016,27:e8.
[8] Ruan X,Li M,Mueck AO.Why does polycystic ovary syndrome(PCOS) need long-term management?[J].Curr Pharm Des,2018,24:4685-4692.
[9] Teede HJ,Misso ML,Costello MF,et al.Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome[J].Fertil Steril,2018,110:364-379.
[10] Campo G,Rebecchi A,Vanni VS,et al.Levonorgestrel-releasing intrauterine system versus oral medroxyprogesterone acetate in infertile women with endometrial hyperplasia without atypia[J/OL].Reprod Biomed Online,2021,43:864-870.
[11] Aldarazi K,Omran H,Jassim NM.Endometrial hyperplasia in asymptomatic subfertile population[J].J Gynecol Obstet Hum Reprod,2022,51:102337.
[12] Lyytinen H,Pukkala E,Ylikorkala O.Breast cancer risk in postmenopausal women using estradiolprogestogen therapy[J].Obstet Gynecol,2009,113:6573.
[13] 娄瑶晨，周爽，廖炯博，等.地屈孕酮与醋酸甲羟孕酮治疗子宫内膜增生不伴非典型性的疗效及安全性比较[J].中华妇产科杂志，2023,58:526-535.
[14] 陈玲玲，何嘏娜，李榕梓，等.左炔诺孕酮宫内缓释系统与地屈孕酮治疗子宫内膜增生的临床疗效观察[J].海峡药学，2023,35:133-136.
[15] Zhang YF,Fan Y,Mu Y,et al.Efficacy of oral medications or intrauterine device-delivered progestin in patients with endometrial hyperplasia with or without atypia:A network meta-analysis[J].J Clin Med,2023,12:2980.
基本信息:
中图分类号:R711.7
引用信息:
[1]张瑞芬,殷华.地屈孕酮用于子宫内膜复杂性增生术后伴PCOS患者治疗获得自然妊娠1例报告并文献复习[J].生殖医学杂志,2025,34(02):249-252.
2025-02-15
2025-02-15